Difficulty: Medium
Average Score: 80%
Practice
Osteosarcoma is the most common primary malignant bone tumor in children and adolescents; it has multiple subtypes and requires different modalities of treatment including surgery and chemotherapy. Of the following, the subtype of osteosarcoma which is treated by surgery alone is
Correct answer
D
Rationale
In this question, the correct answer is D) periosteal. Periosteal osteosarcoma is a subtype that is typically treated by surgery alone without the need for chemotherapy. This is because periosteal osteosarcoma tends to be a low-grade tumor that is more localized and less aggressive compared to other subtypes.
Option A) fibroblastic and Option B) chondroblastic are subtypes that usually require a combination of surgery and chemotherapy for treatment due to their higher aggressiveness and tendency to spread. Option C) parosteal, while a subtype of osteosarcoma, may also require a combination of treatments depending on the extent of the tumor and its characteristics.
Educationally, understanding the different subtypes of osteosarcoma and their respective treatment modalities is crucial for healthcare providers working with pediatric oncology patients. It helps in determining the most appropriate and effective treatment plan for each patient based on the specific characteristics of their tumor, ultimately leading to better outcomes and quality of care.
Option A) fibroblastic and Option B) chondroblastic are subtypes that usually require a combination of surgery and chemotherapy for treatment due to their higher aggressiveness and tendency to spread. Option C) parosteal, while a subtype of osteosarcoma, may also require a combination of treatments depending on the extent of the tumor and its characteristics.
Educationally, understanding the different subtypes of osteosarcoma and their respective treatment modalities is crucial for healthcare providers working with pediatric oncology patients. It helps in determining the most appropriate and effective treatment plan for each patient based on the specific characteristics of their tumor, ultimately leading to better outcomes and quality of care.